BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21482137)

  • 41. Uterine fibroids: diffusion-weighted MR imaging for monitoring therapy with focused ultrasound surgery--preliminary study.
    Jacobs MA; Herskovits EH; Kim HS
    Radiology; 2005 Jul; 236(1):196-203. PubMed ID: 15987974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of Ovarian Artery Embolization for Uterine Fibroids: Clinical and Magnetic Resonance Imaging Evaluations.
    Campbell J; Rajan DK; Kachura JR; Jaskolka J; Beecroft JR; Sniderman KW; Simons ME; Tan KT
    Can Assoc Radiol J; 2015 May; 66(2):164-70. PubMed ID: 25596903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes.
    Kim HS; Baik JH; Pham LD; Jacobs MA
    Acad Radiol; 2011 Aug; 18(8):970-6. PubMed ID: 21718955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas.
    Taran FA; Tempany CM; Regan L; Inbar Y; Revel A; Stewart EA;
    Ultrasound Obstet Gynecol; 2009 Nov; 34(5):572-8. PubMed ID: 19852046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound.
    Stovall DW
    Menopause; 2011 Apr; 18(4):437-44. PubMed ID: 21701430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic resonance imaging-guided focused ultrasound treatment of symptomatic uterine fibroids: impact of technology advancement on ablation volumes in 115 patients.
    Trumm CG; Stahl R; Clevert DA; Herzog P; Mindjuk I; Kornprobst S; Schwarz C; Hoffmann RT; Reiser MF; Matzko M
    Invest Radiol; 2013 Jun; 48(6):359-65. PubMed ID: 23385396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uterine fibroids: Influence of "T2-Rim sign" on immediate therapeutic responses to magnetic resonance imaging-guided high-intensity focused ultrasound ablation.
    Yeo SY; Kim YS; Lim HK; Rhim H; Jung SH; Hwang NY
    Eur J Radiol; 2017 Dec; 97():21-30. PubMed ID: 29153363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scaled signal intensity of uterine fibroids based on T2-weighted MR images: a potential objective method to determine the suitability for magnetic resonance-guided focused ultrasound surgery of uterine fibroids.
    Park H; Yoon SW; Sokolov A
    Eur Radiol; 2015 Dec; 25(12):3455-8. PubMed ID: 25956935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Ultrasound-guided focused ultrasound ablation of intramural, submucosal and subserosal uterine fibroids: 12-month follow-up results].
    Ren D; Wang W; Wang Y; Yao Y; Tang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):978-82. PubMed ID: 25057068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation.
    Kim YS; Lee JW; Choi CH; Kim BG; Bae DS; Rhim H; Lim HK
    Radiology; 2016 Mar; 278(3):925-35. PubMed ID: 26313526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids.
    Quinn SD; Vedelago J; Gedroyc W; Regan L
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():247-51. PubMed ID: 25445107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up.
    Lohle PN; De Vries J; Klazen CA; Boekkooi PF; Vervest HA; Smeets AJ; Lampmann LE; Kroencke TJ
    J Vasc Interv Radiol; 2007 Jul; 18(7):835-41. PubMed ID: 17609441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Uterine arterial embolization for leiomyomas: perfusion and volume changes at MR imaging and relation to clinical outcome.
    deSouza NM; Williams AD
    Radiology; 2002 Feb; 222(2):367-74. PubMed ID: 11818601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leiomyoma volume changes at follow-up after uterine artery embolization: correlation with the initial leiomyoma volume and location.
    Naguib NN; Mbalisike E; Nour-Eldin NE; Jost A; Lehnert T; Ackermann H; Vogl TJ
    J Vasc Interv Radiol; 2010 Apr; 21(4):490-5. PubMed ID: 20149688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique.
    Stewart EA; Gedroyc WM; Tempany CM; Quade BJ; Inbar Y; Ehrenstein T; Shushan A; Hindley JT; Goldin RD; David M; Sklair M; Rabinovici J
    Am J Obstet Gynecol; 2003 Jul; 189(1):48-54. PubMed ID: 12861137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential exploratory use of MR-guided focused ultrasound for disconnection of symptomatic intracavitary submucosal uterine myoma.
    Jung SG; Yoon SW; Park H; Lee C
    J Vasc Interv Radiol; 2011 Nov; 22(11):1635-7. PubMed ID: 22024122
    [No Abstract]   [Full Text] [Related]  

  • 57. Eligibility and accessibility of magnetic resonance-guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomas.
    Behera MA; Leong M; Johnson L; Brown H
    Fertil Steril; 2010 Oct; 94(5):1864-8. PubMed ID: 19931074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efficacy and safety of focused ultrasound ablation in treatment of submucosal uterine fibroids].
    Wang T; Wang W; Chen WZ; Wang YX; Ye HY; Tang J
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):407-11. PubMed ID: 21781578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of high-intensity focused ultrasound guided by magnetic resonance therapy on obstetrical outcomes in patients with uterine fibroids - experiences from the main Polish center and a review of current data.
    Łoziński T; Filipowska J; Gurynowicz G; Zgliczyńska M; Kluz T; Jędra R; Skowyra A; Ciebiera M
    Int J Hyperthermia; 2019; 36(1):582-590. PubMed ID: 31159642
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical 24 month experience of the first MRgFUS unit for treatment of uterine fibroids in Australia.
    Dobrotwir A; Pun E
    J Med Imaging Radiat Oncol; 2012 Aug; 56(4):409-16. PubMed ID: 22883648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.